Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Norsan is a specialized healthcare company headquartered in Berlin, Germany, that focuses on the development and distribution of high-quality Omega-3 fatty acid supplements. Founded with a mission to address the widespread Omega-3 deficiency in the population, the company offers a range of products including natural fish oils and vegan algae-based alternatives. Norsan distinguishes itself through a commitment to high-dose formulations, low oxidation levels (TOTOX value), and the inclusion of antioxidants like organic olive oil. In addition to its product line, the company promotes diagnostic fatty acid analysis to help individuals achieve an optimal Omega-3 Index. Their portfolio supports various therapeutic areas, including cardiovascular health, cognitive function, and inflammatory regulation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Norsan.